Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation
Year of publication: |
April 2018
|
---|---|
Authors: | Müller, Dirk ; Danner, Marion C. ; Rhiem, Kerstin E. M. ; Stollenwerk, Björn ; Engel, Christoph ; Rasche, Linda ; Borsi, Lisa ; Schmutzler, Rita ; Stock, Stephanie |
Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 19.2018, 3, p. 341-353
|
Subject: | Cost-effectiveness | Economic modeling | Breast cancer | Risk-reducing surgery | BRCA | Krebskrankheit | Cancer | Deutschland | Germany | Frauen | Women | Gesundheitsvorsorge | Preventive care | Kosten-Wirksamkeits-Analyse | Cost-effectiveness analysis |
-
Müller, Dirk, (2019)
-
Sun, Li, (2024)
-
Paulissen, Jeroen H. J., (2024)
- More ...
-
Müller, Dirk, (2019)
-
Müller, Dirk, (2015)
-
Cost Effectiveness of Rivaroxaban for Stroke Prevention in German Patients with Atrial Fibrillation
Mensch, Alexander, (2015)
- More ...